SMTL ID : 7ugi.2 (1 other biounit)

Bromodomain of EP300 liganded with BMS-536924

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x N6I: (3M)-4-{[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}-3-[4-methyl-6-(morpholin-4-yl)-1H-benzimidazol-2-yl]pyridin-2(1H)-one(Non-covalent)

N6I.1: 10 residues within 4Å: Chain A: W.70, V.73, W.77, N.81, W.84, S.101, E.105, I.108, D.109, M.112 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:W.70, A:W.77, A:W.77, A:W.77, A:W.77 Hydrogen bonds: A:N.81 pi-Stacking: A:W.77

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 2 residues within 4Å: Chain A: R.59, Q.65 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.59, A:Q.65 EDO.3: 3 residues within 4Å: Chain A: V.34, Y.44, N.87 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.87

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schonbrunn, E. et al., Structural basis of CBP and EP300 interaction with kinase inhibitors. To Be Published

Release Date

2023-04-12

Peptides

Histone acetyltransferase p300: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Histone acetyltransferase p300

Related Entries With Identical Sequence